Northland Capital Markets Downgrades Protagonist Therapeutics (PTGX) to Market Perform, Following Clinical Business Update
Tweet Send to a Friend
Northland Capital Markets analyst Tim Chiang downgraded Protagonist Therapeutics (NASDAQ: PTGX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
